Meet Dr. Jaya TrivediNeurologist in Dallas
Jaya Trivedi, M.D., has dedicated her career to treating challenging neurological conditions; she has particular expertise at caring for patients with neuromuscular disorders.
Dr. Trivedi specializes in treating conditions such as amytrophic lateral sclerosis (ALS), myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIPD), peripheral neuropathy, inflammatory myopathies, and muscular dystrophy.
“I enjoy my work and love taking care of patients,” Dr. Trivedi says. “Some of their disorders can be challenging to treat, but we take on the challenges together.”
Patients travel from around the country to see Dr. Trivedi for a rare category of conditions called muscle channelopathies. These include myotonia congenita, paramyotonia congenita, and periodic paralysis. Through her clinical research and experience with her patients, Dr. Trivedi is now known as one of the experts in the country specializing in muscle channelopathies.
Challenging Disorders Treated Compassionately
Because so many of the conditions Dr. Trivedi treats have no cure, like ALS, much of her patient care includes symptomatic treatment and support.
For autoimmune neuromuscular disorders, such as CIDP, inflammatory myopathies or myasthenia gravis, she treats patients with chronic immunosuppressive therapy that requires rigorous monitoring to make sure they aren’t developing complications.
“Lifelong conditions such as periodic paralysis can be very disabling,” Dr. Trivedi says. “You can use medications to reduce the number of a patient’s paralysis attacks, but you can’t abolish attacks altogether. Often, it’s also about modifying patient’s lifestyle to reduce the paralytic episodes.
Dr. Trivedi and her colleagues at UT Southwestern have also been involved with a number of multi-center clinical trials that resulted in treatments now in common use.
“We’re always searching for new treatments,” Dr. Trivedi says. “New treatments can help patients with neuromuscular disorders lead a better-quality life with fewer symptoms.”